Mary L Faber

Title: Mary L Faber: Innovator in Cancer Treatment

Introduction

Mary L Faber is a prominent inventor based in New Berlin, WI (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of novel antibodies. With a total of 2 patents, her work focuses on advancing therapeutic options for patients suffering from cancer.

Latest Patents

Faber's latest patents include groundbreaking inventions related to Anti-CD30 antibodies. The first patent provides novel antibodies and antigen binding fragments that specifically bind to human CD30. This invention also includes single chain variable antibodies, chimeric antigen receptors, and methods for treating cancer. The second patent similarly focuses on Anti-CD30 antibodies and methods for treating CD30+ cancer, further emphasizing her commitment to improving cancer therapies.

Career Highlights

Throughout her career, Mary L Faber has worked with esteemed institutions such as the Medical College of Wisconsin and the University of Virginia. Her research has been pivotal in developing new methods for cancer treatment, showcasing her dedication to advancing medical science.

Collaborations

Faber has collaborated with notable colleagues, including Everett R Tate and Robyn A A Oldham. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Mary L Faber's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical research and therapy.